Amarin Steps Closer To EU Cardiovascular Risk Market

 
• By Neena Brizmohun
  
Anatomy of Human Heart
Vazkepa is for treating patients at high cardiovascular risk • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography